1. Home
  2. SLE vs SNOA Comparison

SLE vs SNOA Comparison

Compare SLE & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Super League Enterprise Inc.

SLE

Super League Enterprise Inc.

HOLD

Current Price

$4.61

Market Cap

5.2M

ML Signal

HOLD

Logo Sonoma Pharmaceuticals Inc.

SNOA

Sonoma Pharmaceuticals Inc.

HOLD

Current Price

$2.63

Market Cap

6.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLE
SNOA
Founded
2014
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2M
6.1M
IPO Year
2019
2006

Fundamental Metrics

Financial Performance
Metric
SLE
SNOA
Price
$4.61
$2.63
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$60.00
N/A
AVG Volume (30 Days)
24.2K
12.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,064,000.00
$14,288,000.00
Revenue This Year
N/A
$23.00
Revenue Next Year
$26.83
$24.59
P/E Ratio
N/A
N/A
Revenue Growth
90.41
12.19
52 Week Low
$0.10
$1.77
52 Week High
$11.43
$6.92

Technical Indicators

Market Signals
Indicator
SLE
SNOA
Relative Strength Index (RSI) 57.08 25.11
Support Level $4.12 N/A
Resistance Level $6.25 $3.85
Average True Range (ATR) 0.37 0.14
MACD -0.02 -0.02
Stochastic Oscillator 75.87 0.00

Price Performance

Historical Comparison
SLE
SNOA

About SLE Super League Enterprise Inc.

Super League Enterprise Inc is the rocket ship to the metaverse. It is a creator and publisher of content experiences and media solutions across the globe's immersive platforms. Its solutions provide incomparable access to massive audiences that gather in immersive digital spaces to socialize, play, explore, collaborate, shop, learn, and create. The company offers a complete range of development, distribution, monetization, and optimization capabilities designed to engage users through dynamic, energized programs. It generates revenue from advertising, including immersive game world and experience publishing and in-game media products, direct-to-consumer offers, including in-game items, e-commerce, game passes and ticketing and digital collectibles, and content and technology.

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

Share on Social Networks: